Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Authors
Keywords
Apoptosis, Heart, Mitochondria, MAPK signaling cascades, Fluorescence microscopy, Cancer treatment, Cell staining, Antioxidants
Journal
PLoS One
Volume 8, Issue 5, Pages e64526
Publisher
Public Library of Science (PLoS)
Online
2013-05-29
DOI
10.1371/journal.pone.0064526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats
- (2012) AgadihiremathViswanatha Swamy et al. INDIAN JOURNAL OF PHARMACOLOGY
- Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor γ Activation Pathway in Gastric Cancer
- (2012) Lalitha Ramachandran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caspase levels and execution efficiencies determine the apoptotic potential of the cell
- (2012) Anat Florentin et al. JOURNAL OF CELL BIOLOGY
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Isorhamnetin Suppresses Skin Cancer through Direct Inhibition of MEK1 and PI3-K
- (2011) J.-E. Kim et al. Cancer Prevention Research
- Regulator of G Protein Signaling 6 Mediates Doxorubicin-Induced ATM and p53 Activation by a Reactive Oxygen Species-Dependent Mechanism
- (2011) J. Huang et al. CANCER RESEARCH
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation
- (2011) Wei-Tien Chang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation
- (2011) Bing Sun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
- (2011) Yang Xu et al. PLoS One
- Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro
- (2011) Jing Xiao et al. TOXICOLOGY
- Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53
- (2011) Sakhila K. Banu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Critical role of the JNK-p53-GADD45α apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons
- (2010) Hye Joung Choi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice
- (2010) Rajarajan A. Thandavarayan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Reactive oxygen species, cellular redox systems, and apoptosis
- (2010) Magdalena L. Circu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation
- (2010) Qian Liu et al. NEUROCHEMISTRY INTERNATIONAL
- Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation
- (2010) Qingyu Qin et al. PLoS One
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: Potential role of tannins in cancer chemotherapy
- (2010) Kulbhushan Tikoo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition
- (2009) Z. Wang et al. CANCER RESEARCH
- Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury
- (2009) Najuan Zhang et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
- (2009) Masashi Yoshida et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cocoa flavonoids up-regulate antioxidant enzyme activity via the ERK1/2 pathway to protect against oxidative stress-induced apoptosis in HepG2 cells☆
- (2009) María Ángeles Martín et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Antioxidant Properties of Isolated Isorhamnetin from the Sea Buckthorn Marc
- (2009) Liu Pengfei et al. PLANT FOODS FOR HUMAN NUTRITION
- ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
- (2008) Jiahao Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis
- (2008) Hyo-Jung Lee et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation